Atlas Trials

Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)

Clinical trial NCT05423327 · TERMINATED

Trial details

NCT number
NCT05423327
Sponsor
Regeneron Pharmaceuticals
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-alcoholic Steatohepatitis (NASH)
Start date
2021-12-09
Primary completion
2022-10-27
Enrollment
5311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.